PYXS
Pyxis Oncology Inc
2.10$
-2.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.9% | +26.8% | -5.4% | -6.3% | -19.5% | -13.6% | -9.3% | -14.3% | -13.3% | -29.7% | -14.6% | |
| – | -10.4% | +38.3% | -6.6% | -7.6% | -11.0% | -15.5% | -10.7% | -16.9% | -13.2% | -36.8% | -19.4% | |
| – | -34.3% | +189.4% | -10.3% | -51.9% | +61.5% | -34.5% | -15.9% | -16.9% | +72.9% | -53.1% | +160.5% | |
| – | -10.3% | +31.6% | -0.8% | -7.0% | -12.4% | -16.9% | -15.6% | -14.3% | -12.3% | -36.4% | -22.3% | |
| – | – | +37,995.2% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +9.0% | -2.4% | -0.2% | -0.2% | -89.0% | -2.2% | -2.2% | -2.2% | – | – | – | |
| – | -1.5% | -24.9% | +7.0% | +7.9% | -12.5% | -10.1% | +8.6% | +3.5% | +3.5% | -13.3% | +31.6% | |
| – | -9.1% | -45.1% | +19.5% | +20.3% | -13.0% | -18.4% | +22.5% | +9.6% | +9.0% | -21.8% | +66.2% | |
| – | +2.3% | -17.2% | +31.2% | +4.1% | +4.1% | +4.0% | +4.0% | +4.0% | +3.8% | +3.8% | +3.8% | |
| – | +17.7% | -41.1% | +138.6% | -11.0% | -0.2% | -41.4% | +230.7% | +3.7% | +11.6% | -54.2% | -34.5% | |
| – | -8.9% | +46.5% | -7.8% | -9.5% | -21.4% | -14.6% | -15.0% | -21.5% | -22.3% | -41.5% | -63.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +8.3% | +14.6% | +17.9% | +0.4% | +0.0% | +0.5% | +1.4% | +1.0% | -0.7% | +2.1% | +0.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.